Results 151 to 160 of about 151,984 (257)

Associations of HALP score with serum prostate-specific antigen and mortality in middle-aged and elderly individuals without prostate cancer. [PDF]

Front Oncol
Chen Z, Zhang Y, Dan M, Hong X, Chen S, Zhong X.   +5 more
europepmc   +1 more source

IGFBP3 As a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma: A Multi‐Cohort Analysis

Journal of Clinical Laboratory Analysis, EarlyView.
This study demonstrates that insulin‐like growth factor‐binding protein 3 (IGFBP3) exhibits a dual role in hepatocellular carcinoma (HCC), being significantly downregulated in tumor tissues compared to normal liver, yet its high expression within tumors is strongly associated with advanced disease and poor prognosis.
Yin Tao, Yunji Xu, Xupeng Chen, Yali Zhou, Jingli Fu   +4 more
wiley   +1 more source

A cross-sectional study of the association between depression and serum prostate-specific antigen (PSA) among U.S. males: national health and nutrition examination survey (NHANES), 2005-2010. [PDF]

BMC Psychiatry
Huang Y, Wang Y, Su H, Zhang Y.
europepmc   +1 more source

Tobacco and marijuana use and their association with serum prostate-specific antigen levels among African American men in Chicago. [PDF]

Prev Med Rep, 2020
Press DJ, Pierce B, Lauderdale DS, Aschebrook-Kilfoy B, Lin Gomez S, Hedeker D, Wright NE, Fantus RJ, Bettencourt L, Ahsan H, Eggener S.   +10 more
europepmc   +1 more source

Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml. [PDF]

Indian J Nucl Med, 2021
Soni BK, Verma P, Shah AK, Singh R, Sonawane S, Asopa RV.   +5 more
europepmc   +1 more source

Analytical and Workflow Performance of a High‐Throughput Chemiluminescent Immunoassay System in a Clinical Laboratory

Journal of Clinical Laboratory Analysis, EarlyView.
Analytical and operational performance evaluation of the DxI 9000 Access Immunoassay Analyzer in a clinical laboratory in Taiwan. ABSTRACT Background Increasing test volumes and shorter turnaround time (TAT) requirements, particularly in acute‐care settings, challenge clinical laboratories to maintain accurate immunoassay testing.
Chiung‐Tzu Hsiao, Chao‐Ching Liao, Yu‐Chang Chang, Hui‐Ju Chang, Tz‐Ya Huang, Jen‐Shiou Lin, Po‐Ren Hsueh   +6 more
wiley   +1 more source

Serum prostate-specific antigen level changes may also play an important role in chronic prostatitis patients receiving THREM therapy. [PDF]

Transl Androl Urol
Lin HF, Li HK, Chung SD.
europepmc   +1 more source

Molecular theranostics: principles, challenges and controversies

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 156-164, March 2025.
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley   +1 more source

A two‐stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 93-105, March 2025.
This study developed a two‐stage model using radiomics‐based multiparametric MRI and clinical indicators to help identify and grade clinically significant prostate cancer. The model showed promising levels of diagnostic accuracy and predictive performance.
Yuyan Zou, Xuechun Wang, Fen Ma, Xulun Liu, Chunyue Jiao, Zhen Kang, Jingjing Cui, Yang Zhang, Yan Xie, Lei Chen, Ronghua Tian   +10 more
wiley   +1 more source

Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A Systematic Review and Meta-Analysis. [PDF]

Diagnostics (Basel), 2021
Han S, Woo S, Kim YI, Lee JL, Wibmer AG, Schoder H, Ryu JS, Vargas HA.   +7 more
europepmc   +1 more source